Here, we demonstrate that patients with lipedema consistently acknowledge and describe nociceptive pain, that this pain is measurable by an objective mechanical allodynia response, and that lipedema dermal tissue contains significant differences in neuronal cell body and neuropeptide distribution potentially driving neuronal sensitization. The gene discussed is NPS; the disease is Lipedema.